SCHEMBL7988676

SCHEMBL7988676

NCCc1nc(=O)c2c(ncn2Cc2cccc(Cl)c2)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
GLA P06280 1/20 0.47
HTT P42858 1/20 0.47
UBE2N P61088 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PARN O95453 1/20 0.42
CNOT7 Q9UIV1 1/20 0.42
YTHDC1 Q96MU7 3/20 0.42
PIK3CD O00329 1/20 0.42
PIK3CB P42338 1/20 0.42
FSCN1 Q16658 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ACP1 P24666 1/20 0.40
MAPK1 P28482 1/20 0.40
P2RX7 Q99572 1/20 0.39
EGFR P00533 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991727 0.89 SMN1; SMN2 (0.49) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985640 0.89 CNOT7 (0.53) SMN1; SMN2PARNCNOT7
Hydrochloric Acid SCHEMBL7987619 0.88 CNOT7 (0.52) SMN1; SMN2PARNCNOT7
SCHEMBL7988534 0.87 TAAR1 (0.41) PARNCNOT7TAAR1EGFR
SCHEMBL7992187 0.87 ALDH1A1 (0.43) SMN1; SMN2HTTPARNCNOT7TAAR1
SCHEMBL7984758 0.87 SMN1; SMN2 (0.51) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7987676 0.85 SMN1; SMN2 (0.49) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985278 0.85 TP53 (0.50) YTHDC1TAAR1
Hydrochloric Acid SCHEMBL7987808 0.84 SMN1; SMN2 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988672 0.83 SMN1; SMN2 (0.47) SMN1; SMN2GLAHTTUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed